Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1222 COVID-19 vaccination in Botswana
NCT05715944Phase 3Completed
- Sponsor
- Botswana Harvard AIDS Institute Partnership
- Start
- Sep 2021
- Primary completion
- Dec 2022
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by Botswana Harvard AIDS Institute Partnership. Started Sep 2021; status: completed.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05715944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05715944.